News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Machine learning model predicts radiotherapy response in nasopharyngeal carcinoma patients using gene expression data.
The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to drive modest growth and improve future ...
The report offers a detailed analysis of the microbiome sequencing market, segmented by component, sequencing technology, laboratory type, application, and end user. It explores t ...
From salty rivers to oceans full of plastic, new eco-friendly solutions and maps easily indicating global risks are giving ...
Accumulus Synergy Spins Out Accumulus Technologies to Scale Proven Regulatory Platform and Accelerate Global Access to Therapies ...
With Annual NTM Case Rates Rising, Patients and Providers Are Urged to Recognize the Symptoms and Risks Experience the full interactive Multichannel News Release here: NTM lung disease is caused by ...
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient ...
Legionnaires’ disease causes a unique post-infection syndrome, potentially reshaping long-term pneumonia recovery care.
An AI-powered MRI model enables faster and highly accurate plaque detection in carotid arteries, transforming stroke ...
A collaborative research team led by Hong Kong Baptist University (HKBU) has developed a multifunctional nanorobot equipped with silver and gold nanorods to facilitate high-performance pollutant ...
Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ABT-301, enabling the initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results